Hospitalised neonates in Estonia commonly receive potentially harmful excipients

BMC Pediatrics

Volumn 12, Issue , 2012, Pages

  Lass, Jana ^a,b   Naelapää, Kaisa ^c   Shah, Utpal ^d   Käär, Ruth ^e   Varendi, Heili ^f   Turner, Mark A ^g,h   Lutsar, Irja ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^e TALLINN CHILDREN S HOSPITAL   (Estonia)

^f TARTU UNIVERSITY HOSPITAL   (Estonia)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Harmful excipient; Neonate

Indexed keywords

ALCOHOL; ANHYDROUS SODIUM HYDROGEN PHOSPHATE; BENZALKONIUM CHLORIDE; BENZOIC ACID; BENZYL ALCOHOL; BICARBONATE; BORATE SODIUM; BORIC ACID; CETOSTEARYLIC ALCOHOL; COLLOIDAL ANHYDROUS SILICA; CRESOL; CYCLAMATE SODIUM; EDETATE DISODIUM; EXCIPIENT; GELATIN; LACTIC ACID; MACROGOL; MALTOSE; PARABENS (METHYL AND PROPYL PARAHYDROXYBENZOATE); POLYSORBATE 80; POVIDONE; PROPYLENE GLYCOL; SACCHARIN SODIUM; SODIUM LAURYL SULPHATE; SODIUM METABISULFITE; SORBIC ACID; SORBITAN STEARATE; TROLAMINE; TROMETAMOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL PAIN; ADVERSE DRUG REACTION; ANAPHYLAXIS; ARTICLE; ASCITES; BREATHING DISORDER; BRONCHOSPASM; CENTRAL NERVOUS SYSTEM DEPRESSION; CEREBROVASCULAR DISEASE; CHEST TIGHTNESS; CHILD CARE; CHILD HOSPITALIZATION; CHOLESTASIS; CONTACT DERMATITIS; CONTACT URTICARIA; CONVULSION; DIARRHEA; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG INTOXICATION; DRUG SAFETY; DYSPNEA; E FEROL SYNDROME; ESTONIA; EYE IRRITATION; FATAL TOXIC SYNDROME; GRANULOMA; HEADACHE; HEART FAILURE; HEPATOMEGALY; HUMAN; HYPERBILIRUBINEMIA; HYPEROSMOLARITY; HYPERPYREXIA; HYPONATREMIA; HYPOTENSION; INFLAMMATION; INJECTION SITE PAIN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; LIVER DISEASE; MAJOR CLINICAL STUDY; METABOLIC ACIDOSIS; METABOLIC DISORDER; MUCOSAL DISEASE; MUSCLE DISEASE; NAUSEA; NEWBORN; OTOTOXICITY; PHOTOSENSITIVITY DISORDER; PRESCRIPTION; PRURITUS; RASH; RESPIRATORY TRACT DISEASE; SARCOIDOSIS; SEIZURE; SIDE EFFECT; SKIN ALLERGY; SKIN IRRITATION; STOMACH IRRITATION; SUBCUTANEOUS GRANULOMA; THROMBOCYTOPENIA; URTICARIA; VERTIGO; VISUAL IMPAIRMENT; VOMITING; WHEEZING;

COHORT STUDIES; EXCIPIENTS; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PROSPECTIVE STUDIES;

EID: 84865425371     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-12-136     Document Type: Article

References (31)

1. American Academy of Pediatrics, Committee on Drugs Inactive ingredients in pharmaceutical products: update (subject review). Pediatrics 1997, 99:268-278. American Academy of Pediatrics, Committee on Drugs.
2. Hall C, Milligan D, Berrington J. Probable adverse reaction to a pharmaceutical excipient. Arch Dis Child Fetal Neonatal Ed 2004, 89(2):F184. 10.1136/adc.2002.024927, 1756023, 14977910.
3. Masi S, Cléty D, Clément S, Anslot C, Detaille T. Acute amiodarone toxicity due to an administration error: could excipient be responsible?. Br J Clin Pharmacol 2009, 67(6):691-693. 10.1111/j.1365-2125.2008.03323.x, 2723211, 19076154.
4. Peleg O, Bar-Oz B, Arad I. Coma in a premature infant associated with the transdermal absorption of propylene glycol. Acta Paediatrica 1998, 87(11):1195-1196. 10.1111/j.1651-2227.1998.tb00930.x, 9846924.
5. DeMerlis CC, Goldring JM, Velagaleti R, Brock W, Osterberg R. Regulatory Update: The IPEC Novel Excipient Safety Evaluation Procedure. Pharm Technol 2009, 33(11):72-82.
6. Food and Drug Administration Guidance for Industry Nonclinical Safety Evaluation of Pediatric Drug Products 2006, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079247.pdf. Accessed November, 14, 2011., Food and Drug Administration.
7. European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Guideline on excipients in the dossier for application for marketing authorisation of a medicinal product 2007, CHMP/QWP/396951/06, European Medicines Agency Committee for Medicinal Products for Human Use (CHMP).
8. European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Reflection paper: Formulations of choice for the paediatric population 2006, http://www.emea.europa.eu/pdfs/human/paediatrics/19481005en.pdf. Accessed August, 11, 2011, European Medicines Agency Committee for Medicinal Products for Human Use (CHMP).
9. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med 2003, 349(12):1157-1167. 10.1056/NEJMra035092, 13679531.
10. Phelps DL. E-Ferol: What happened and what now?. Paediatrics 1984, 74:1114-1116.
11. Tuleu C. Paediatric formulation in practice. Paediatric drug handling 2007, 43. London: Pharmaceutical Press, Costello I, Long PF, Wong I, Tuleu C, Yeung V, first.
12. Golightly LK, Smolinske SS, Bennett ML, Sutherland EW. Rumack BH. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I). Medical Toxicology and Adverse Drug Experience 1988, 3:128-165.
13. Whittaker A, Currie AE, Turner MA, Field DJ, Mulla H, Pandya HC. Toxic additives in medication for preterm infants. Arch Dis Child Fetal Neonatal Ed 2009, 94(4):F236-F240. 10.1136/adc.2008.146035, 19158148.
14. Ursino MG, Poluzzi E, Caramella C, Ponti FD. Excipients in medicinal products used in gastroenterology as a possible cause of side effects. Regul Toxicol Pharmacol 2011, 60:93-105. 10.1016/j.yrtph.2011.02.010, 21354240.
15. Standing JF, Tuleu C. Paediatric formulations-Getting to the heart of the problem. Int J Pharm 2005, 300(1-2):56-66.
16. Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit Care Med 2009, 10(2):256-259. 10.1097/PCC.0b013e31819a383c, 19188870.
17. Lass J, Käär R, Jõgi K, Varendi H, Metsvaht T, Lutsar I. Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol 2011, 67:1263-1271. 10.1007/s00228-011-1072-x, 21667125.
18. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients 2009, London: Pharmaceutical Press, 6.
19. European Commission The Rules Governing Medicinal Products in the European Union. Excipients in the Label and Package leaflet of Medicinal Products for Human Use 2003, http://pharmacos.eudra.org/F2/eudralex/vol-3/pdfs-en/3bc7a_200307en.pdf. Accessed August, 2011, 2011, European Commission.
20. Fabiano V, Mameli C, Zuccotti GV. Paediatric pharmacology: Remember the excipients. Pharmacol Res 2011, 63:362-365. 10.1016/j.phrs.2011.01.006, 21241804.
21. Paediatric Drug Handling 2007, Great Britain: Pharmaceutical Press, Costello I, Long PF, Wong IK, Tuleu C, Yeung V.
22. Solà R, Boj M, Hernandez-Flix S, Camprubí M. Silica in oral drugs as a possible sarcoidosis-inducing antigen. Lancet 2009, 373(9679):1943-1944. 10.1016/S0140-6736(09)61057-6, 19501734.
23. Singh M, Winhoven S, Beck M. Contact sensitivity to octyldodecanol and trometamol in an anti-itch cream. Contact Derm 2007, 56(5):289-290. 10.1111/j.1600-0536.2006.00990.x, 17441857.
24. WHO Possibly titanium dioxide carcinogenic to humans 2011, WHO: IARC Monograp, http://www.google.ee/search?hl=et&client=firefox-a&hs=V5f&rls=org.mozilla:en-US:official&sa=X&ei=LVVPTpjsIorf4QTn2dW9Bw&ved=0CIMBEAUoAA&q=Possibly+titanium+dioxide+carcinogenic+to+humans.+%28WHO%3A+IARC+Monograph&spell=1&biw. Accessed September, 8, 2011, WHO.
25. Braun S, Werdehausen R, Gaza N, Hermanns H, Kremer D, Küry P, et al. Benzethonium increases the cytotoxicity of (S)-ketamine in lymphoma, neuronal, and glial cells. Anesth Analg 2010, 111(6):1389-1393. 10.1213/ANE.0b013e3181f690e4, 20889936.
26. Mpountoukas P, Pantazaki A, Kostareli E, Christodoulou P, Kareli D, Poliliou S, et al. Cytogenetic evaluation and DNA interaction studies of the food colorants amaranth, erythrosine and tartrazine. Food Chem Toxicol 2010, 48(10):2934-2944. 10.1016/j.fct.2010.07.030, 20667460.
27. Asakawa H, Araki T, Yamamoto N, Imai I, Yamane M, Tsutsumi Y, et al. Allergy to ethylenediamine and steroid. J Investig Allergol Clin Immunol 2000, 10(6):372-374.
28. van Riet-Nales DA, de Jager KE, Schobben AFAM, Egberts TCG, Rademaker C. The availability and age-appropriateness of medicines authorized for children in the Netherlands. Br J Clin Pharmacol 2011, 72(3):465-473. 10.1111/j.1365-2125.2011.03982.x, 3175516, 21477143.
29. Allegaert K, Vanhaesebrouck S, Kulo A, Cosaert K, Verbesselt R, Debeer A, et al. Prospective assessment of short-term propylene glycol tolerance in neonates. Arch Dis Child 2010, 95(12):1054-1058. 10.1136/adc.2010.190330, 20959360.
30. Cram A, Breitkreutz J, Desset-Brèthes S, Nunn T, Tuleu C. Challenges of developing palatable oral paediatric formulations. Int J Pharm 2009, 365(1-2):1-3.
31. Yakkundi S, McElnay J, Millership J, Mulla H, Pandya H, Shah U, et al. Use of dried blood spots to study excipient kinetics in neonates. Bioanalysis 2011, 3(24):2691-2693. 10.4155/bio.11.277, 22185265.